People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

PHOENIX (AZFamily) — A ketamine-derived nasal spray is now available for the millions of Americans living with severe depression. The hallucinogenic drug is an option when traditional treatment isn’t ...

An estimated 21 million American adults suffer from clinical depression. © 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes ...

CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment ... of participants taking the placebo. “When Johnson & Johnson started researching Spravato ...

How can you make therapy work best for you? Here are a few tips. And a new study offers more evidence that teens are in trouble.

Johnson & Johnson's Spravato therapy for treatment ... "This provides further evidence for the use of esketamine nasal spray in this difficult-to-treat population and offers hope for the millions ...

The U.S. Food and Drug Administration recently expanded approval of the nasal spray SPRAVATO, a ketamine-derived drug, as a ...